Vien Phan Email & Phone Number

London, Gb

I provide independent advisory services focussing on the definition through to delivery and execution of high growth corporate and business strategies covering: finance, operations, fundraising, corporate strategy, M&A and integration.I support businesses in their pursuit of high growth, high impact strategies that maximise shareholder value.Expertise in capital markets and financial markets infrastructure and B2B/enterprise business models. Other industry experiences in biotechnology, life sciences, business services, alternative finance, crypto and payments.Example clients: portfolio companies of venture and growth equity capital investors, investment firms of varying sizes with private and public company mandates and investment strategies, sovereign wealth funds.Flexible engagement model: Interim, Perm, Part-time, Project based, Portfolio.

London, Gb

GrowCFO is a global community built by and for ambitious finance leaders. We help you build the professional and personal skills, confidence and connections you need to achieve your full potential.Members receive exclusive access to peer group development programmes, on-demand training resources, executive mentoring, collaborative events, insightful content and more. We have helped thousands of finance professionals through innovative capability assessments, personalised action plans and practical resources.

London, England, Gb

Investing in the technology foundations of the future.Bloc is a specialist deep tech early stage investor. We back ambitious entrepreneurs building products across cloud, connectivity, data science and security with the potential to impact whole industries.Reporting to co-Founder and CEO.Executive Committee member and voting Investment Committee member.Responsible for all aspects of finance and operations incl. cash management, capital allocation, investor reporting, governance, control and compliance, people, legal, portfolio management and review, corporate technology, real estate.Lots of hands-on work with the investment portfolio companies inc. legal and interim CFO type work.

London, London, Gb

Supporting the Shawpoint team to serve their clients.https://www.shawpoint.com/Investment Banking and City Access for SMEs

Bering Waters Group forms a trio of companiesVENTURES focuses on research-heavy innovations in the blockchain and cryptocurrency spaceTECH envisions and implements innovative solutions to accelerate mass adoption of Distributed Ledger TechnologyOTC DESK for unreleased tokens and forward contracts for altcoinshttps://beringwaters.com/

Oxford, Gb

Alethiomics, a drug discovery company focused on developing targeted therapies to treat a family of blood cancers called myeloproliferative neoplasms (MPNs) backed by £6m seed financing from Oxford Science Enterprises.A spin-out from the University of Oxford, the company is based on world-leading discoveriesin clinical haematology and single-cell multi-omics.Reporting to Executive Chairman. Responsible for all aspects of finance and operations enabling the team to focus on moving the science forwards.Highlights:+ Runway extension+ Seed investment drawdown+ 1st R&D tax credit process+ Implement 1st LTIP scheme+ Upgraded financial reporting, cashflow forecasting and revised Budget+ 1st statutory accounts+ Optimise finops processes e.g. order to cash cycle inc. banking operations+ SVB bank run crisis management

London, Gb

Exploring the angel networks and ecosystems in the UK and enjoying meeting amazing Foundershttps://www.alma-angels.com/

Oxford, Gb

Reporting to CEO and co-Founder, I was responsible for all aspects of finance and business operations for a Seed -> Series A vaccine biotechnology start-up company, venture capital (VC) funded by Oxford Sciences Enterprises and GV, formally Google Ventures.A hands-on business building role spanning all aspects of company building outside of product e.g., compliance, control and reporting, FP&A, cash, FX and treasury management, investor relations, change, operations (legal, HR / people, corporate technology, facilities), advisory relationships, communications, governance, fundraising.Highlights: I partnered with the CEO, co-Founder and other shareholders to deliver:> co-led definition, launch and closing company’s funding strategy and investor roadshow, resulting fundraising £10m convertible debt transaction (HMT Future Fund); subsequent $32.5m Series A equity financing> co-led to signing the company's 1st technology out-licencing deal for a COVID-19 vaccine (clinical stage) and first £millions 3rd party revenue> co-led the search and subsequent onboarding for an upgraded Board, Chair, Scientific Advisory Board, and expanded management team inc. my perm full-time replacement> property strategy review -> set up a US subsidiary (legal entity) and UK real estate lease renewal > managed multiple co-Founder exits and/or contract and consultant relationship renegotiations> total reward and benefits review and people strategy -> set up inaugural HMRC approved EMI share option program inc. UK and US valuation inputs> expansion of company advisory network across finance, tax, comms, IP, contract and commercial law, HR

Some personal and professional projects.Property renovations, travel, family.

London, England, Gb

Functional lead for Group corporate strategy, corporate development and strategic planning and a direct report to Group CFO.Member of Group Leadership teamMember of Group Investment CommitteeMember of Group Finance ExCoOver a 10 year period, I contributed to a 16x market capitalisation growth of the company which is now a £40bn+ (by enterprise value), established FTSE25 business. In a variety of corporate development roles, I supported the delivery of a transformational corporate strategy from a UK equities trading business to a global financial markets infrastructure leader. This was executed by successful delivery of ambitious organic plans and targeted, strategic large and bolt–on acquisitions and synergies realisation programmes. In financial terms over a 10 year period (Mar 08 - Mar 18), the company delivered a sector-leading: c.17% Revenue CAGRc.15% EPS CAGR over 950% Total Shareholder Return

London, England, Gb

London, England, Gb

London, England, Gb

London, England, Gb

Gb

ICAS qualified / member. Financial audit and assuranceStrategy Consulting Transaction ServicesCapital Markets AdvisorySectors: Technology, Media, Telco, Oil & Gas, Business ServicesClients: FTSE100 and FTSE250, private equity

Gb

Zurich, Ch

Mbioch, Molecular And Cellular Biochemistry

Education record